NI-0801 in Allergic Contact Dermatitis
NCT01244607 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2010-11-19
Summary
The purpose of the study is to assess the effect of a single dose of NI-0801 on the severity of nickel-induced allergic contact dermatitis.
Conditions
- Allergic Contact Dermatitis
Interventions
- DRUG
-
single i.v. administration
- DRUG
-
NI-0801
single i.v. administration
Sponsors & Collaborators
-
Light Chain Bioscience - Novimmune SA
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
More Related Trials
-
Short Repeated Nickel Exposures
NCT03309215 ·Status: COMPLETED ·Phase: NA
-
The Role of Bacterial Toxins in Human Skin Disease
NCT02910791 ·Status: UNKNOWN
-
Comparative Safety Study of New Sinecort Formulation Versus Positive Control
NCT00885937 ·Status: COMPLETED ·Phase: PHASE1
-
Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis
NCT00843466 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
NCT00644917 ·Status: COMPLETED ·Phase: PHASE1
-
Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis
NCT00196430 ·Status: COMPLETED ·Phase: PHASE3
-
Epicutaneous Testing of Cosmetics for Skin Compatibility
NCT03024671 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous
NCT01429701 ·Status: COMPLETED ·Phase: PHASE3
-
Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis
NCT00868842 ·Status: COMPLETED
-
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
NCT02932891 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Reactions in Contact Dermatitis Affected Skin
NCT01546298 ·Status: COMPLETED
-
Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica
NCT04492618 ·Status: COMPLETED ·Phase: PHASE2
-
Identification of Epidermal Signatures in Patients With Atopic Dermatitis
NCT02680405 ·Status: UNKNOWN
-
Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream
NCT04807751 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline
NCT04202263 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis
NCT00883311 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Diagnosis of Allergic Contact Dermatitis (SMECA).
NCT06124781 ·Status: RECRUITING ·Phase: NA
-
Xerotic Dermatitis in Aged People
NCT01806935 ·Status: COMPLETED ·Phase: NA
-
Treating Patients With a History of Non-Life Threatening Allergic Reaction to Penicillin With Penicillin
NCT00363688 ·Status: TERMINATED ·Phase: PHASE4
-
Assessment of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis
NCT06331390 ·Status: RECRUITING ·Phase: NA
-
Determination of Sensitive Skin and Its Biophysical Response in a Latin-American Population
NCT01591993 ·Status: COMPLETED ·Phase: PHASE4
-
Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
NCT03835767 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annulare
NCT05580042 ·Status: COMPLETED ·Phase: PHASE1
-
MicroRNA-126 and Its Target VCAM-1Dermatitis to Nickel
NCT04365140 ·Status: COMPLETED
-
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
NCT04882631 ·Status: COMPLETED ·Phase: PHASE1